468 related articles for article (PubMed ID: 19642149)
1. Closing in on ending the warfarin era for stroke prevention in nonvalvular atrial fibrillation.
Turi ZG
Catheter Cardiovasc Interv; 2009 Aug; 74(2):223-4. PubMed ID: 19642149
[No Abstract] [Full Text] [Related]
2. Left atrial appendage occlusion for the reduction of stroke and embolism in patients with atrial fibrillation.
Gibson DN; Price MJ; Ahern TS; Teirstein PS
J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):131-7. PubMed ID: 22193834
[No Abstract] [Full Text] [Related]
3. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
Mant JW
Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
[No Abstract] [Full Text] [Related]
4. WATCHMAN matches warfarin.
Expert Rev Cardiovasc Ther; 2009 May; 7(5):456. PubMed ID: 19419252
[No Abstract] [Full Text] [Related]
5. Stroke in heart failure: atrial fibrillation revisited?
Pullicino P; Homma S
J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):1-2. PubMed ID: 20123219
[No Abstract] [Full Text] [Related]
6. Left atrial appendage closure.
Lin AC; Knight BP
Prog Cardiovasc Dis; 2015; 58(2):195-201. PubMed ID: 26241302
[TBL] [Abstract][Full Text] [Related]
7. Is it safe to stop anticoagulants after successful surgery for atrial fibrillation?
Michael Gray R; Nagendran M; Maruthappu M
Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):642-8. PubMed ID: 21885540
[TBL] [Abstract][Full Text] [Related]
8. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
Hylek EM
Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
[No Abstract] [Full Text] [Related]
9. Warfarin: is the end nigh? Please?
Neilson RF
J R Coll Physicians Edinb; 2010 Sep; 40(3):222-3. PubMed ID: 21127766
[No Abstract] [Full Text] [Related]
10. Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients.
Lane DA; Lip GY
Thromb Haemost; 2009 May; 101(5):802-5. PubMed ID: 19404530
[No Abstract] [Full Text] [Related]
11. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
Selçuk H; Selçuk MT; Maden O
Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
[TBL] [Abstract][Full Text] [Related]
12. Is Apixaban (Eliquis) the "ideal" anticoagulant to replace warfarin for stroke prevention in atrial fibrillation?
Strain J; Templeton K
S D Med; 2013 Jan; 66(1):20-1. PubMed ID: 23342716
[No Abstract] [Full Text] [Related]
13. Stroke prevention in atrial fibrillation.
Mohammed I; Mohmand-Borkowski A; Burke JF; Kowey PR
J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):73-85. PubMed ID: 22193836
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
15. Intensity of anticoagulation in octogenarians with nonvalvular atrial fibrillation.
Jolobe OM
J Am Geriatr Soc; 2008 Oct; 56(10):1967-8. PubMed ID: 19054207
[No Abstract] [Full Text] [Related]
16. A cautionary note on data sources for evidence-based clinical decisions: warfarin and stroke prevention.
Thomson R; Eccles M; Wood R; Chinn DJ
Med Decis Making; 2007; 27(4):438-47. PubMed ID: 17641140
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of pharmacologic and invasive therapies for stroke prophylaxis in atrial fibrillation.
Solomon MD; Ullal AJ; Hoang DD; Freeman JV; Heidenreich P; Turakhia MP
J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):86-96. PubMed ID: 22193838
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation in the octogenarian with atrial fibrillation.
Kapoor M; McNicoll L
Med Health R I; 2009 Apr; 92(4):152-4. PubMed ID: 19452760
[TBL] [Abstract][Full Text] [Related]
19. South Africa's poor warfarin control raises questions of benefit above other anticoagulant therapies in atrial fibrillation.
Aalbers J
Cardiovasc J Afr; 2011; 22(4):220. PubMed ID: 21881695
[No Abstract] [Full Text] [Related]
20. Prevention of stroke in patients with atrial fibrillation.
Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
[No Abstract] [Full Text] [Related]
[Next] [New Search]
